Literature DB >> 22474947

Flowers from Kalanchoe pinnata are a rich source of T cell-suppressive flavonoids.

Marcela A S Coutinho1, Michelle F Muzitano, Elaine A Cruz, Maria C Bergonzi, Carlos R Kaiser, Luzineide W Tinoco, Anna R Bilia, Franco F Vincieric, Bartira Rossi-Bergmann, Sônia S Costa.   

Abstract

The chemical composition and immunosuppressive potential of the flowers from Kalanchoe pinnata (Crassulaceae) were investigated. We found that the aqueous flower extract was more active than the leaf extract in inhibiting murine T cell mitogenesis in vitro. Flavonoids isolated from the flower extract were identified and quantitated based on NMR and HPLC-DAD-MS analysis, respectively. Along with quercetin, four quercetin glycosyl conjugates were obtained, including quercetin 3-O-beta-D-glucuronopyranoside and quercetin 3-O-beta-D-glucopyranoside, which are described for the first time in K. pinnata. All flavonoids inhibited murine T cell mitogenesis and IL-2 and IL-4 production without cell toxicity. This is the first report on the pharmacological activity of flowers of a Kalanchoe species, which are not used for curative purposes. Our findings show that K. pinnata flowers are a rich source of T-suppressive flavonoids that may be therapeutically useful against inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22474947

Source DB:  PubMed          Journal:  Nat Prod Commun        ISSN: 1555-9475            Impact factor:   0.986


  2 in total

1.  The Effect of Standardised Leaf Extracts of Gaultheria procumbens on Multiple Oxidants, Inflammation-Related Enzymes, and Pro-Oxidant and Pro-Inflammatory Functions of Human Neutrophils.

Authors:  Piotr Michel; Sebastian Granica; Karolina Rosińska; Małgorzata Glige; Jarosław Rojek; Łukasz Poraj; Monika Anna Olszewska
Journal:  Molecules       Date:  2022-05-23       Impact factor: 4.927

2.  Mechanisms Underlying the Antinociceptive, Antiedematogenic, and Anti-Inflammatory Activity of the Main Flavonoid from Kalanchoe pinnata.

Authors:  Raquel Teixeira Ferreira; Marcela Araújo Soares Coutinho; David do Carmo Malvar; Elson Alves Costa; Iziara Ferreira Florentino; Sônia Soares Costa; Frederico Argollo Vanderlinde
Journal:  Evid Based Complement Alternat Med       Date:  2014-12-11       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.